Literature DB >> 15035882

A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.

Joanna Eng1, Darlene Ramsum, Marja Verhoef, Emma Guns, Joyce Davison, Richard Gallagher.   

Abstract

PURPOSE: To determine prevalence and patterns of use of complementary and alternative medicine (CAM) among men recently diagnosed with prostate cancer. STUDY
DESIGN: Men, diagnosed with prostate cancer over a 10-month period in British Columbia, Canada, were randomly selected to obtain a population-based sample.
METHODS: Surveys, addressing patient demographics, types of CAM therapies, and CAM information resources utilized, reasons for use, and disclosure to physician(s), were mailed to 1108 men newly diagnosed with prostate cancer. A 42% response rate was obtained.
RESULTS: Thirty-nine percent of patients used CAM therapies with the most common being herbal supplements (saw palmetto), vitamins (vitamin E), and minerals (selenium). The most common reasons given for choosing to use CAM therapies were to (1) boost the immune system and (2) prevent recurrence. The majority of men (58%) had told their physician(s) about their CAM use, but few utilized either their family physician (15%) or their oncologist (7%) as sources of CAM information. CAM users most commonly consulted friends or family (39%) or the Internet (19%) for information about CAM. CAM users were more likely than nonusers to delay (9%) or decline (4%) conventional treatment. Respondents who had never used CAM had typically never thought about it or did not have enough information about the treatments.
CONCLUSIONS: More than one third of recently diagnosed prostate cancer patients utilize some form of CAM therapy, and the majority disclose their use to their physician(s). However, they tend to rely on anecdotal information for their CAM decision making. Dissemination of reliable CAM information is one key to helping men navigate this difficult arena.

Entities:  

Mesh:

Year:  2003        PMID: 15035882     DOI: 10.1177/1534735403256207

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  32 in total

1.  Use of complementary and alternative medicine among men with prostate cancer in a rural setting.

Authors:  Susan Butler; Ashli Owen-Smith; Colleen DiIorio; Michael Goodman; Jonathan Liff; Kyle Steenland
Journal:  J Community Health       Date:  2011-12

2.  Developing an operational model for an integrative oncology program: a qualitative descriptive feasibility study.

Authors:  Laura Weeks; Dugald Seely; Cathy DeGrasse; Shailendra Verma; Heather Boon; Marja Verhoef; Dawn Stacey
Journal:  Support Care Cancer       Date:  2013-11-13       Impact factor: 3.603

Review 3.  What patients take without telling you: holistic approach for BPH.

Authors:  Jillian L Capodice; Aaron E Katz
Journal:  World J Urol       Date:  2006-09       Impact factor: 4.226

Review 4.  Commonly used methods of complementary medicine in the treatment of breast cancer.

Authors:  Jutta Hübner; Volker Hanf
Journal:  Breast Care (Basel)       Date:  2013-10       Impact factor: 2.860

5.  Wishes and beliefs of cancer patients regarding counseling on integrative medicine.

Authors:  Karsten Münstedt; Tobias Vogt; Maria-Elisabeth Rabanus; Jutta Hübner
Journal:  Breast Care (Basel)       Date:  2014-12       Impact factor: 2.860

6.  Complementary and alternative medicine use among newly diagnosed prostate cancer patients.

Authors:  Cara L McDermott; David K Blough; Catherine R Fedorenko; Neeraj K Arora; Steven B Zeliadt; Megan E Fairweather; Ingrid Oakley-Girvan; Stephen K Van Den Eeden; Scott D Ramsey
Journal:  Support Care Cancer       Date:  2010-12-01       Impact factor: 3.603

7.  Patients with advanced cancer and their usage of complementary and alternative medicine.

Authors:  Magda Paul; B Davey; B Senf; C Stoll; K Münstedt; R Mücke; Oliver Micke; F J Prott; J Buentzel; Jutta Hübner
Journal:  J Cancer Res Clin Oncol       Date:  2013-07-06       Impact factor: 4.553

Review 8.  Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review.

Authors:  Esther L Davis; Byeongsang Oh; Phyllis N Butow; Barbara A Mullan; Stephen Clarke
Journal:  Oncologist       Date:  2012-08-29

9.  Canadian integrative oncology research priorities: results of a consensus-building process.

Authors:  L C Weeks; D Seely; L G Balneaves; H S Boon; A Leis; D Oneschuk; S M Sagar; M J Verhoef
Journal:  Curr Oncol       Date:  2013-08       Impact factor: 3.677

10.  Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial.

Authors:  Channing J Paller; Xian C Zhou; Elisabeth I Heath; Mary-Ellen Taplin; Tina Mayer; Mark N Stein; Glenn J Bubley; Roberto Pili; Tamaro Hudson; Radhika Kakarla; Muneer M Abbas; Nicole M Anders; Donna Dowling; Serina King; Ashley B Bruns; William D Wagner; Charles G Drake; Emmanuel S Antonarakis; Mario A Eisenberger; Samuel R Denmeade; Michelle A Rudek; Gary L Rosner; Michael A Carducci
Journal:  Clin Cancer Res       Date:  2017-11-07       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.